Intended for healthcare professionals

  1. News & Views
  2. Developing a vaccine...
  3. Developing a vaccine against Zika
Editorials

Developing a vaccine against Zika

BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5923 (Published 10 November 2016) Cite this as: BMJ 2016;355:i5923

All rapid responses

Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles or when it is brought to our attention that a response spreads misinformation.

From March 2022, the word limit for rapid responses will be 600 words not including references and author details. We will no longer post responses that exceed this limit.

The word limit for letters selected from posted responses remains 300 words.

Eliminating vectors is quicker and cheaper

Nowadays, CRISPR-cas9 gene editing has quickly and successfully managed to engineer Aedes species carriers of many new catastrophic genes, stable transmission of mutant alleles to progenies, reduced fertility mosquitoes, etc. [1][2][3]
Even necessary funding for breeding and distribution of these genetically modified mosquitoes is provided by Charities.
Only political will, cooperation between various Countries, and elimination of corruption remain, in order to completely eradicate Zika virus infections from the Planet.
References
[1] http://www.bmj.com/content/353/bmj.i2548
[2] http://www.cell.com/cell-reports/abstract/S2211-1247(15)00262-4
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394034/

Competing interests: No competing interests

16 November 2016
Stavros Saripanidis
Consultant in Obstetrics and Gynaecology
Thessaloniki, Greece
Back to top